PL2998305T3 - Kryształ soli trilitowej chinonu pirolochinoliny, sposób jego otrzymywania i zastosowanie - Google Patents

Kryształ soli trilitowej chinonu pirolochinoliny, sposób jego otrzymywania i zastosowanie

Info

Publication number
PL2998305T3
PL2998305T3 PL14819418T PL14819418T PL2998305T3 PL 2998305 T3 PL2998305 T3 PL 2998305T3 PL 14819418 T PL14819418 T PL 14819418T PL 14819418 T PL14819418 T PL 14819418T PL 2998305 T3 PL2998305 T3 PL 2998305T3
Authority
PL
Poland
Prior art keywords
preparation
application
lithium salt
salt crystal
pyrroloquinoline quinone
Prior art date
Application number
PL14819418T
Other languages
English (en)
Inventor
Chunjiu Zhong
Xuefeng Mei
Huan ZHANG
Original Assignee
Shanghai Ri Xin Biotechnology Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Ri Xin Biotechnology Co. Ltd. filed Critical Shanghai Ri Xin Biotechnology Co. Ltd.
Publication of PL2998305T3 publication Critical patent/PL2998305T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
PL14819418T 2013-07-01 2014-06-23 Kryształ soli trilitowej chinonu pirolochinoliny, sposób jego otrzymywania i zastosowanie PL2998305T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310270885.2A CN103351387B (zh) 2013-07-01 2013-07-01 吡咯喹啉醌锂盐晶体及其制备方法和应用
EP14819418.6A EP2998305B1 (en) 2013-07-01 2014-06-23 Pyrroloquinoline quinone lithium salt crystal and preparation method and application thereof
PCT/CN2014/080542 WO2015000370A1 (zh) 2013-07-01 2014-06-23 吡咯喹啉醌锂盐晶体及其制备方法和应用

Publications (1)

Publication Number Publication Date
PL2998305T3 true PL2998305T3 (pl) 2020-11-02

Family

ID=49307822

Family Applications (1)

Application Number Title Priority Date Filing Date
PL14819418T PL2998305T3 (pl) 2013-07-01 2014-06-23 Kryształ soli trilitowej chinonu pirolochinoliny, sposób jego otrzymywania i zastosowanie

Country Status (8)

Country Link
US (1) US9738639B2 (pl)
EP (1) EP2998305B1 (pl)
JP (1) JP6130595B2 (pl)
CN (1) CN103351387B (pl)
ES (1) ES2794078T3 (pl)
PL (1) PL2998305T3 (pl)
PT (1) PT2998305T (pl)
WO (1) WO2015000370A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017114844A (ja) * 2015-12-22 2017-06-29 三菱瓦斯化学株式会社 認識能力向上食品
CN112274513B (zh) * 2020-12-28 2021-03-26 上海日馨生物科技有限公司 含有吡咯喹啉醌三锂盐九水化合物的药物组合物、胶囊剂及其制备方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101193888A (zh) * 2005-03-24 2008-06-04 Clf医疗技术加速程序有限公司 吡咯喹啉醌(pqq)的合成方法
EP2062892A4 (en) * 2006-09-08 2009-11-18 Kyowa Hakko Bio Co Ltd MEDIUM AGAINST HYPERTONIA
CN101851234A (zh) * 2009-04-03 2010-10-06 上海日馨生物科技有限公司 吡咯喹啉醌锂盐衍生物及其制备方法
CN101885725A (zh) * 2009-05-12 2010-11-17 江苏道琪生物科技有限公司 吡咯喹啉醌钠盐衍生物及其制备方法
JP2011026812A (ja) 2009-07-23 2011-02-10 Mano Kogyo Kk 引込管の施工方法
JP5636671B2 (ja) * 2009-12-17 2014-12-10 三菱瓦斯化学株式会社 ピロロキノリンキノンLi塩の製造方法

Also Published As

Publication number Publication date
CN103351387B (zh) 2016-03-02
ES2794078T3 (es) 2020-11-17
EP2998305A1 (en) 2016-03-23
EP2998305B1 (en) 2020-04-08
JP6130595B2 (ja) 2017-05-17
US9738639B2 (en) 2017-08-22
PT2998305T (pt) 2020-07-09
WO2015000370A1 (zh) 2015-01-08
EP2998305A4 (en) 2017-01-04
CN103351387A (zh) 2013-10-16
BR112015031797A2 (pt) 2017-07-25
US20160137641A1 (en) 2016-05-19
JP2016522224A (ja) 2016-07-28

Similar Documents

Publication Publication Date Title
EP3068240A4 (en) Theacrine-based supplement and method of use thereof
EP3089989A4 (en) Cas9 crystals and methods of use thereof
EP3016199A4 (en) Electrolytic solution and battery
SG11201507897SA (en) Salt of pyrazoloquinoline derivative, and crystal thereof
EP3050191A4 (en) Apparatus and method to change current limit
HRP20170874T1 (hr) Formulacija kontrastnog medija i odgovarajući postupak dobivanja
ZA201503159B (en) Small crystal ferrierite and method of making the same
SG10201912293UA (en) Stable crystal form of tipiracil hydrochloride and crystallization method for the same
EP2980178A4 (en) SEALANT AND MANUFACTURING METHOD THEREFOR
SI2930169T1 (sl) Kristalna oblika hidamida, pripravljalni postopek in njena uporaba
IL234923A0 (en) Electrolyte system and methods for its preparation
IL245272A0 (en) pif-transfected cells and methods of use
PL2805952T3 (pl) Krystaliczna forma soli (6S)-5-metylotetrahydrofolianowej oraz sposób jej przygotowywania
EP3269710A4 (en) Nintedanib diethanesulfonate salt crystal and preparation method and use thereof
PT2998305T (pt) Cristal de sal de lítio de pirroloquinolina quinona e seu método de preparação e aplicação
EP3033795A4 (en) Lithium sulfur cell and preparation method
SG11201507073UA (en) Method for manufacturing liquid-crystal display cells and liquid-crystal display cells obtained via said method
EP3021414A4 (en) Nonaqueous electrolyte solution kit and method for preparing nonaqueous electrolyte solution
GB201310256D0 (en) Stereoscopic display and method
GB2515174B (en) Electrochemical apparatus and method
AP3759A (en) Method for preparing phenyloxymethyl-nitro-imidazole derivatives and use of the same
EP3000807A4 (en) Mercaptonicotinic acid compound and preparation method and use thereof
EP3067403A4 (en) Sealant composition and preparation method therefor
AU2013901572A0 (en) Thermo-Electrochemical Cell and Method of Use
AU2013904954A0 (en) Lithium Battery Assembly and Method of Use